Novartis highlights new CTL019 clinical data showing complete remissions in children and young adults with relapsed/refractory acute lymphoblastic leukemia

Novartis highlights new CTL019 clinical data showing complete remissions in children and young adults with relapsed/refractory acute lymphoblastic leukemia

Dec 06, 2014

Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia-0